These are the current treatment protocols that HNE Health, NSW has in place:
- HNELHD CG 21_35 COVID-19 Inpatient Management Adults 24Aug21
- HNELHD_CG_21_38_Inpatient_Clinical_Management_of_COVID-19_in_Paediatrics 19Jul21
The evidence base is as per the Australian National Covid-19 Evidence Taskforce which has a robust approach to evidence assessment (strength and quality).
Important recent updates from them :
Conditional recommendation: “Consider using inhaled budesonide for the treatment of symptomatic COVID-19 in adults who do not require oxygen and who have one or more risk factors for disease progression.”
- Ivermectin FAQ – https://covid19evidence.net.au/faqs/#Ivermectin
“The Taskforce has issued a strong recommendation against the use of ivermectin outside of randomised trials: Do not use ivermectin for the treatment of COVID-19 outside of randomised trials with appropriate ethical approval. “